Chiu and coworkers focused on spontaneous preclinical models of hepatocarcinoma with distinct immunotypes and demonstrated that an activated EPO/EPO-R pathway can induce immunosuppression by binding to EPO-R on tumor–associated macrophages. This evidence concerns the gene EPO and neoplasm.